Aingo Pharma Private Limited, a active private limited company, was established on 25 September 2013 in Manimajra, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232CH2013PTC034743. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ram Gopal (Director), Sanjay Kumar Garg (Director). Past directors included Manju Jain, Ram Gopal, Jeet Kumar Jain. It holds ₹1.25 Cr open charges and ₹2.40 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Scf-32, Ground Floor, Motor Market, Manimajra, Chandigarh, 160101.
U24232CH2013PTC034743
034743
25 September 2013
₹0.10 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Aingo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ram Gopal | Director | 05 Dec 2014 | Current |
| Sanjay Kumar Garg | Director | 18 Aug 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 09 Apr 2019 | Past |
| Pramod Abcsdd | Director | 10 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aingo Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.21% increase. The company also saw a slight improvement in profitability, with a 2% increase in profit. The company's net worth Soared by an impressive increase of 30.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aingo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,500,000.00
₹2,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2024 | Others | ₹7.50 M | Open |
| 13 Oct 2023 | Others | ₹5.00 M | Open |
| 31 Jan 2017 | Hdfc Bank Limited | ₹2.40 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aingo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aingo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aingo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aingo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 7.50 M with Charge ID 100919953 was registered on 27 Apr 2024. was documented.
Aingo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100794507 was registered on 13 Oct 2023. was documented.
Progress on A charge registered on 31 Jan 2017 via Charge ID 100085094 with Hdfc Bank Limited was fully satisfied on 02 Sep 2023. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 2.40 M with Charge ID 100085094 was registered on 31 Jan 2017. was completed.
The CIN of Aingo Pharma Private Limited is U24232CH2013PTC034743.
Aingo Pharma Private Limited is headquartered at Scf-32, Ground Floor, Motor Market, Manimajra, Chandigarh, 160101.
Aingo Pharma Private Limited was incorporated on 25 September 2013.
The current directors of Aingo Pharma Private Limited are
The primary industry of Aingo Pharma Private Limited is Trade.
Aingo Pharma Private Limited is unlisted.
The authorized capital of Aingo Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aingo Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX